Summary: CytoReason launches AI disease model platform

Why It Matters: The website moved from a loading screen to a full site. It shows how they use data to predict if drugs will work. This helps drug companies save money and time.

What Changed:

• Added a new section about "Disease Models" that map how drugs work in the body.
• Added a tool to help drug companies manage and compare their different medicine programs.
• Added a news section featuring a partnership with NVIDIA for reading scientific papers.
• Added a "living data" feature that updates models with the latest human data.
• Added a quote from a Pfizer executive comparing their tech to "engineering."